Company Filing History:
Years Active: 1992-1997
Title: The Innovations of Robert A. Deich
Introduction
Robert A. Deich is a notable inventor based in Rochester, NY, with a significant contribution to the field of biotechnology. He holds five patents that showcase his expertise in genetic engineering and immunology. His work has had a profound impact on vaccine development and the understanding of bacterial infections.
Latest Patents
One of his latest patents is focused on "Genes for the export of pertussis holotoxin." This invention relates to a cloned region of the Bordetella pertussis genome, which is crucial for the expression, assembly, and secretion of pertussis holotoxin. The patent also describes methods for increasing holotoxin production using various hosts. Another significant patent is for "Recombinant vectors for Haemophilus influenzae peptides and proteins." This patent details peptides and proteins related to an outer membrane protein of Haemophilus influenzae. It includes novel purification methods and recombinant DNA techniques to produce these proteins, which are essential for vaccine formulations and immunoassays.
Career Highlights
Throughout his career, Robert A. Deich has worked with prominent companies such as Praxis Biologics, Inc. and American Cyanamid Company. His experience in these organizations has allowed him to develop innovative solutions in the field of biotechnology.
Collaborations
He has collaborated with notable individuals in his field, including Gary Warren Zlotnick and Bruce Arthur Green. These partnerships have contributed to the advancement of his research and inventions.
Conclusion
Robert A. Deich's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of vaccines and the understanding of infectious diseases.